Abstract:Background: The key to reducing the immense morbidity and mortality burdens of cardiovascular diseases is to help people keep their blood pressure (BP) at safe levels. This requires that more people with hypertension be identified, diagnosed, and given tools to lower their BP. BP monitors are critical to hypertension diagnosis and management. However, there are characteristics of conventional BP monitors (oscillometric cuff sphygmomanometers) that hinder rapid and effective hypertension diagnosis and management. Calibration-free, software-only BP monitors that operate on ubiquitous mobile devices can enable on-demand BP monitoring, overcoming the hardware barriers of conventional BP monitors. Objective: This study aims to investigate the accuracy of a contactless BP monitor software app for classifying the full range of clinically relevant BPs as hypertensive or nonhypertensive and to evaluate its accuracy for measuring the pulse rate (PR) and BP of people with BPs relevant to stage-1 hypertension. Methods: The software app, known commercially as Lifelight, was investigated following the data collection and data analysis methodology outlined in International Organization for Standardization (ISO) 81060-2:2018/AMD 1:2020 "Non-invasive Sphygmomanometers-Part 2: Clinical investigation of automated measurement type." This validation study was conducted by the independent laboratory Element Materials Technology Boulder (formerly Clinimark). The study generated data from 85 people aged 18-85 years with a wide-ranging distribution of BPs specified in ISO 81060-2:2018/AMD 1:2020. At least 20% were required to have Fitzpatrick scale skin tones of 5 or 6 (ie, dark skin tones). The accuracy of the app's BP measurements was assessed by comparing its BP measurements with measurements made by dual-observer manual auscultation using the same-arm sequential method specified in ISO 81060-2:2018/AMD 1:2020. The accuracy of the app's PR measurements was assessed by comparing its measurements with concurrent electroencephalography-derived heart rate values. Results: The app measured PR with an accuracy root-mean-square of 1.3 beats per minute and mean absolute error of 1.1 (SD 0.8) beats per minute. The sensitivity and specificity with which it determined that BPs exceeded the in-clinic systolic threshold for hypertension diagnosis were 70.1% and 71.7%, respectively. These rates are consistent with those reported for conventional BP monitors in a literature review by The National Institute for Health and Care Excellence. The app's mean error for measuring BP in the range of normotension and stage-1 hypertension (ie, 65/85, 76% of participants) was 6.5 (SD 12.9) mm Hg for systolic BP and 0.4 (SD 10.6) mm Hg for diastolic BP. Mean absolute error was 11.3 (SD 10.0) mm Hg and 8.6 (SD 6.8) mm Hg, respectively. Conclusions: A calibration-free, software-only medical device was independently tested against ISO 81060-2:2018/AMD 1:2020. The safety and performance demonstrated in this study suggest that this technique could be a potential solution for rapid and scalable screening and management of hypertension.

O30 AVAILABILITY OF PROPERLY VALIDATED AUTOMATED BLOOD PRESSURE MEASURING DEVICES FOR CHILDREN: STRIDE BP SYSTEMATIC REVIEW

P074 STRIDE BP SYSTEMATIC REVIEW OF PUBLISHED VALIDATION STUDIES OF BLOOD PRESSURE MEASURING DEVICES

O32 AVAILABILITY OF PROPERLY VALIDATED BLOOD PRESSURE MEASURING DEVICES FOR PREGNANT WOMEN: STRIDE BP SYSTEMATIC REVIEW

Accuracy of cuff-less, continuous, and non-invasive blood pressure measurement in 24-h ABPM in children aged 5-17

Wearable cuffless blood pressure monitoring devices: a systematic review and meta-analysis

Validation of the Meditech ABPM-06 24-hour blood pressure monitoring system in a pediatric population according to International Organization for Standardization Protocol 81060-2:2018

P077 IS THERE A DIFFERENCE IN THE ACCURACY OF AUTOMATED BLOOD PRESSURE DEVICES DESIGNED FOR HOME OR IN-CLINIC USE? A SYSTEMATIC REVIEW AND META-ANALYSIS OF VALIDATION STUDIES

P064 SYSTEMATIC REVIEW OF PROPORTION OF FEMALES AND MALES RECRUITED IN BLOOD PRESSURE DEVICE VALIDATION STUDIES AND RELATIONSHIP WITH MEASUREMENT ACCURACY

PS-C11-7: STUDY OF 24-HOUR CUFF-LESS, CONTINUOUS AND NON-INVASIVE BLOOD PRESSURE MEASUREMENT IN 100 CHILDREN AND ADOLESCENTS SHOWS CLINICAL VALIDITY

Noninvasive pediatric blood pressure assessment: exploring the clinicians’ perspective

P066 HOW BLOOD PRESSURE DEVICES ARE OBTAINED FOR HOME BLOOD PRESSURE MEASUREMENT: A MIXED-METHODS STUDY AMONG AUSTRALIA ADULTS

Automated 'oscillometric' blood pressure measuring devices: how they work and what they measure

O20 CURRENT 24-HOUR AMBULATORY BLOOD PRESSURE TECHNOLOGIES SHOULD BE RECONSIDERED AS THE REFERENCE STANDARD FOR VALIDATION OF CUFFLESS BLOOD PRESSURE DEVICES

Validation protocols for blood pressure-measuring devices: status quo and development needs

Ability of a 24-h ambulatory cuffless blood pressure monitoring device to track blood pressure changes in clinical practice

Accuracy of the WatchBP Office Central as a Type 2 device for non-invasive estimation of central aortic blood pressure in children and adolescents

CURRENT STATUS OF USE OF VALIDATED DEVICES FOR HOME BLOOD PRESSURE MONITORING AMONG PATIENTS WITH HYPERTENSION

Pediatric Home Blood Pressure Monitoring: Feasibility and Concordance With Clinic-Based Manual Blood Pressure Measurements

Validation of two automatic sphygmomanometers according to the modified International Standardization Organization 81060-2:2018 protocol in adults with a mid-upper arm circumference of 22 centimeters or less

Contactless and Calibration-Free Blood Pressure and Pulse Rate Monitor for Screening and Monitoring of Hypertension: Cross-Sectional Validation Study

Achieving reliable blood pressure measurements in clinical practice: It's time to meet the challenge